Copyright Reports & Markets. All rights reserved.

COVID-19 Impact on Global Pediatrics Medicine Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Pediatrics Medicine Revenue
  • 1.4 Market Analysis by Type
    • 1.4.1 Global Pediatrics Medicine Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Enteral
    • 1.4.3 Parenteral
  • 1.5 Market by Application
    • 1.5.1 Global Pediatrics Medicine Market Share by Application: 2020 VS 2026
    • 1.5.2 Respiratory diseases
    • 1.5.3 Infectious diseases
    • 1.5.4 Gastrointestinal diseases
    • 1.5.5 CNS diseases
    • 1.5.6 Oncological diseases
    • 1.5.7 CVDs
    • 1.5.8 Others
  • 1.6 Coronavirus Disease 2019 (Covid-19): Pediatrics Medicine Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Pediatrics Medicine Industry
      • 1.6.1.1 Pediatrics Medicine Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Pediatrics Medicine Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Pediatrics Medicine Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends by Regions

  • 2.1 Pediatrics Medicine Market Perspective (2015-2026)
  • 2.2 Pediatrics Medicine Growth Trends by Regions
    • 2.2.1 Pediatrics Medicine Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Pediatrics Medicine Historic Market Share by Regions (2015-2020)
    • 2.2.3 Pediatrics Medicine Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Pediatrics Medicine Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Pediatrics Medicine Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Pediatrics Medicine Players by Market Size
    • 3.1.1 Global Top Pediatrics Medicine Players by Revenue (2015-2020)
    • 3.1.2 Global Pediatrics Medicine Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Pediatrics Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Pediatrics Medicine Market Concentration Ratio
    • 3.2.1 Global Pediatrics Medicine Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Pediatrics Medicine Revenue in 2019
  • 3.3 Pediatrics Medicine Key Players Head office and Area Served
  • 3.4 Key Players Pediatrics Medicine Product Solution and Service
  • 3.5 Date of Enter into Pediatrics Medicine Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)

  • 4.1 Global Pediatrics Medicine Historic Market Size by Type (2015-2020)
  • 4.2 Global Pediatrics Medicine Forecasted Market Size by Type (2021-2026)

5 Pediatrics Medicine Breakdown Data by Application (2015-2026)

  • 5.1 Global Pediatrics Medicine Market Size by Application (2015-2020)
  • 5.2 Global Pediatrics Medicine Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Pediatrics Medicine Market Size (2015-2020)
  • 6.2 Pediatrics Medicine Key Players in North America (2019-2020)
  • 6.3 North America Pediatrics Medicine Market Size by Type (2015-2020)
  • 6.4 North America Pediatrics Medicine Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Pediatrics Medicine Market Size (2015-2020)
  • 7.2 Pediatrics Medicine Key Players in Europe (2019-2020)
  • 7.3 Europe Pediatrics Medicine Market Size by Type (2015-2020)
  • 7.4 Europe Pediatrics Medicine Market Size by Application (2015-2020)

8 China

  • 8.1 China Pediatrics Medicine Market Size (2015-2020)
  • 8.2 Pediatrics Medicine Key Players in China (2019-2020)
  • 8.3 China Pediatrics Medicine Market Size by Type (2015-2020)
  • 8.4 China Pediatrics Medicine Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Pediatrics Medicine Market Size (2015-2020)
  • 9.2 Pediatrics Medicine Key Players in Japan (2019-2020)
  • 9.3 Japan Pediatrics Medicine Market Size by Type (2015-2020)
  • 9.4 Japan Pediatrics Medicine Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Pediatrics Medicine Market Size (2015-2020)
  • 10.2 Pediatrics Medicine Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Pediatrics Medicine Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Pediatrics Medicine Market Size by Application (2015-2020)

11 India

  • 11.1 India Pediatrics Medicine Market Size (2015-2020)
  • 11.2 Pediatrics Medicine Key Players in India (2019-2020)
  • 11.3 India Pediatrics Medicine Market Size by Type (2015-2020)
  • 11.4 India Pediatrics Medicine Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Pediatrics Medicine Market Size (2015-2020)
  • 12.2 Pediatrics Medicine Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Pediatrics Medicine Market Size by Type (2015-2020)
  • 12.4 Central & South America Pediatrics Medicine Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 GSK
    • 13.1.1 GSK Company Details
    • 13.1.2 GSK Business Overview and Its Total Revenue
    • 13.1.3 GSK Pediatrics Medicine Introduction
    • 13.1.4 GSK Revenue in Pediatrics Medicine Business (2015-2020))
    • 13.1.5 GSK Recent Development
  • 13.2 Novartis
    • 13.2.1 Novartis Company Details
    • 13.2.2 Novartis Business Overview and Its Total Revenue
    • 13.2.3 Novartis Pediatrics Medicine Introduction
    • 13.2.4 Novartis Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.2.5 Novartis Recent Development
  • 13.3 Pfizer
    • 13.3.1 Pfizer Company Details
    • 13.3.2 Pfizer Business Overview and Its Total Revenue
    • 13.3.3 Pfizer Pediatrics Medicine Introduction
    • 13.3.4 Pfizer Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.3.5 Pfizer Recent Development
  • 13.4 Sanofi
    • 13.4.1 Sanofi Company Details
    • 13.4.2 Sanofi Business Overview and Its Total Revenue
    • 13.4.3 Sanofi Pediatrics Medicine Introduction
    • 13.4.4 Sanofi Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.4.5 Sanofi Recent Development
  • 13.5 Abbott
    • 13.5.1 Abbott Company Details
    • 13.5.2 Abbott Business Overview and Its Total Revenue
    • 13.5.3 Abbott Pediatrics Medicine Introduction
    • 13.5.4 Abbott Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.5.5 Abbott Recent Development
  • 13.6 Bristol-Myers Squibb
    • 13.6.1 Bristol-Myers Squibb Company Details
    • 13.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
    • 13.6.3 Bristol-Myers Squibb Pediatrics Medicine Introduction
    • 13.6.4 Bristol-Myers Squibb Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.6.5 Bristol-Myers Squibb Recent Development
  • 13.7 Cipla
    • 13.7.1 Cipla Company Details
    • 13.7.2 Cipla Business Overview and Its Total Revenue
    • 13.7.3 Cipla Pediatrics Medicine Introduction
    • 13.7.4 Cipla Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.7.5 Cipla Recent Development
  • 13.8 Eisai Pharmaceuticals
    • 13.8.1 Eisai Pharmaceuticals Company Details
    • 13.8.2 Eisai Pharmaceuticals Business Overview and Its Total Revenue
    • 13.8.3 Eisai Pharmaceuticals Pediatrics Medicine Introduction
    • 13.8.4 Eisai Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.8.5 Eisai Pharmaceuticals Recent Development
  • 13.9 Eli Lilly
    • 13.9.1 Eli Lilly Company Details
    • 13.9.2 Eli Lilly Business Overview and Its Total Revenue
    • 13.9.3 Eli Lilly Pediatrics Medicine Introduction
    • 13.9.4 Eli Lilly Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.9.5 Eli Lilly Recent Development
  • 13.10 F. Hoffman-La Roche
    • 13.10.1 F. Hoffman-La Roche Company Details
    • 13.10.2 F. Hoffman-La Roche Business Overview and Its Total Revenue
    • 13.10.3 F. Hoffman-La Roche Pediatrics Medicine Introduction
    • 13.10.4 F. Hoffman-La Roche Revenue in Pediatrics Medicine Business (2015-2020)
    • 13.10.5 F. Hoffman-La Roche Recent Development
  • 13.11 Glenmark
    • 10.11.1 Glenmark Company Details
    • 10.11.2 Glenmark Business Overview and Its Total Revenue
    • 10.11.3 Glenmark Pediatrics Medicine Introduction
    • 10.11.4 Glenmark Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.11.5 Glenmark Recent Development
  • 13.12 Helsinn Healthcare
    • 10.12.1 Helsinn Healthcare Company Details
    • 10.12.2 Helsinn Healthcare Business Overview and Its Total Revenue
    • 10.12.3 Helsinn Healthcare Pediatrics Medicine Introduction
    • 10.12.4 Helsinn Healthcare Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.12.5 Helsinn Healthcare Recent Development
  • 13.13 Heron Therapeutics
    • 10.13.1 Heron Therapeutics Company Details
    • 10.13.2 Heron Therapeutics Business Overview and Its Total Revenue
    • 10.13.3 Heron Therapeutics Pediatrics Medicine Introduction
    • 10.13.4 Heron Therapeutics Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.13.5 Heron Therapeutics Recent Development
  • 13.14 Ipca Laboratories
    • 10.14.1 Ipca Laboratories Company Details
    • 10.14.2 Ipca Laboratories Business Overview and Its Total Revenue
    • 10.14.3 Ipca Laboratories Pediatrics Medicine Introduction
    • 10.14.4 Ipca Laboratories Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.14.5 Ipca Laboratories Recent Development
  • 13.15 Lupin Pharmaceuticals
    • 10.15.1 Lupin Pharmaceuticals Company Details
    • 10.15.2 Lupin Pharmaceuticals Business Overview and Its Total Revenue
    • 10.15.3 Lupin Pharmaceuticals Pediatrics Medicine Introduction
    • 10.15.4 Lupin Pharmaceuticals Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.15.5 Lupin Pharmaceuticals Recent Development
  • 13.16 Merck Sharp & Dohme
    • 10.16.1 Merck Sharp & Dohme Company Details
    • 10.16.2 Merck Sharp & Dohme Business Overview and Its Total Revenue
    • 10.16.3 Merck Sharp & Dohme Pediatrics Medicine Introduction
    • 10.16.4 Merck Sharp & Dohme Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.16.5 Merck Sharp & Dohme Recent Development
  • 13.17 RedHill
    • 10.17.1 RedHill Company Details
    • 10.17.2 RedHill Business Overview and Its Total Revenue
    • 10.17.3 RedHill Pediatrics Medicine Introduction
    • 10.17.4 RedHill Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.17.5 RedHill Recent Development
  • 13.18 Sun Pharmaceutical Industries
    • 10.18.1 Sun Pharmaceutical Industries Company Details
    • 10.18.2 Sun Pharmaceutical Industries Business Overview and Its Total Revenue
    • 10.18.3 Sun Pharmaceutical Industries Pediatrics Medicine Introduction
    • 10.18.4 Sun Pharmaceutical Industries Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.18.5 Sun Pharmaceutical Industries Recent Development
  • 13.19 Takeda Pharmaceutical
    • 10.19.1 Takeda Pharmaceutical Company Details
    • 10.19.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
    • 10.19.3 Takeda Pharmaceutical Pediatrics Medicine Introduction
    • 10.19.4 Takeda Pharmaceutical Revenue in Pediatrics Medicine Business (2015-2020)
    • 10.19.5 Takeda Pharmaceutical Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    This report focuses on the global Pediatrics Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Pediatrics Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    GSK
    Novartis
    Pfizer
    Sanofi
    Abbott
    Bristol-Myers Squibb
    Cipla
    Eisai Pharmaceuticals
    Eli Lilly
    F. Hoffman-La Roche
    Glenmark
    Helsinn Healthcare
    Heron Therapeutics
    Ipca Laboratories
    Lupin Pharmaceuticals
    Merck Sharp & Dohme
    RedHill
    Sun Pharmaceutical Industries
    Takeda Pharmaceutical

    Market segment by Type, the product can be split into
    Enteral
    Parenteral
    Market segment by Application, split into
    Respiratory diseases
    Infectious diseases
    Gastrointestinal diseases
    CNS diseases
    Oncological diseases
    CVDs
    Others

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Pediatrics Medicine status, future forecast, growth opportunity, key market and key players.
    To present the Pediatrics Medicine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Pediatrics Medicine are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Buy now